Table 3 Associations between urinary contents of ketamine and metabolites and clinicopathological features of KA.

From: Association of urinary ketamine and APOA1 levels with bladder dysfunction in ketamine abusers revealed via proteomics and targeted metabolite analyses

Item

Feature (case no.)

K

NK

DHNK

r

p-value

r

p-value

r

p-value

1

Urine RBC (n = 44)

0.209

0.207

0.083

0.610

0.177

0.257

2

Urine WBC (n = 44)

0.127

0.447

 − 0.045

0.781

0.061

0.699

3

Serum creatinine (n = 46)

0.210

0.193

0.226

0.149

0.210

0.166

4

OABSS (n = 41)

0.338

0.038

0.348

0.030

0.463

0.003

5

Pain rating scale (n = 40)

0.358

0.030

0.255

0.122

0.231

0.158

  1. K ketamine, NK norketamine, DHNK dehydronorketamine, OABSS overactive bladder syndrome score.